Navigation Links
Kendle Chairman and CEO Receives Lifetime Achievement Award at Cincinnati USA Innovation Awards
Date:4/18/2011

CINCINNATI, April 18, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced Chairman and Chief Executive Officer Candace Kendle, PharmD, is the recipient of the inaugural Lifetime Achievement Award for Innovation from the Cincinnati USA Regional Chamber. Presented by the Cincinnati USA Regional Chamber, the Business Courier and CincyTech, the Innovation Awards celebrate innovative companies and people that show how new ideas can be developed into fuel for the Tri-State's economic engine. Dr. Kendle received her award at a reception held April 14 in Cincinnati.

"I am honored and truly humbled to receive this lifetime achievement award from my peers," said Dr. Kendle.  "Kendle is a global company, but Cincinnati is its home.  I'm proud to have co-founded and developed a successful business in my hometown that over the past 30 years has contributed to the development of life-saving and life-enhancing therapies for millions of patients worldwide – including those here at home.  Cincinnati has quietly become a center of excellence in the biopharmaceutical and high-tech medical industries, and I'm so pleased to have contributed to this important infrastructure within our local economy."

Dr. Kendle co-founded Kendle in 1981 with Executive Vice President and Chief Administrative Officer, Christopher Bergen.  Under her leadership, Kendle has advanced from a small consulting business to one of the largest global Phase I-IV clinical research organizations today with offices in 31 countries across North America, Europe, Asia/Pacific, Latin America and Africa.

"We are thrilled to present the Lifetime Achievement Award to Dr. Kendle for her contributions to the life sciences industry in Cincinnati," said Ellen van der Horst, President of the Cincinnati USA Regional Chamber. "Dr. Kendle has been a champion for scientific education, supporting her alma mater, the University of Cincinnati, and making contributions to the Cincinnati USA economy."

Dr. Kendle is respected globally as a leader in clinical research and has been presented with a variety of international, national and local awards.  She is the recipient of a 2010 honorary Doctor of Science degree from the University of Cincinnati; was named one of the "100 most inspiring people" by leading biopharmaceutical trade publication PharmaVOICE in 2010; and was the winner of the 2009 "Entrepreneurial Champion" Luminary award from the Committee of 200, an international organization of preeminent businesswomen. For more than a decade, Dr. Kendle has served on the Board of Directors of H.J. Heinz Company, a $10 billion+ food company. She also has served on the Board of Trustees at the University of Cincinnati, the National Underground Railroad Freedom Center and numerous other not-for-profit institutions.    

Kendle, which in 2011 marks its 30th year in the CRO industry and its 14th as a publicly held company, has been headquartered in Cincinnati since its founding.  As announced Feb. 14, Dr. Kendle will step into a new role on May 1 as non-executive Chairman of the Board, with Senior Vice President and Chief Operating Officer Stephen Cutler, PhD succeeding her as President and CEO.  

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. For more information, please visit www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
2. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
3. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
4. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
5. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
6. Kendle Launches New Global Biostatistics Infrastructure
7. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
8. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
9. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
10. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
11. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- Corin Group announced today the launch of the Humelock ... with both a massive rotator cuff tear and a ... cuff tear arthropathy, causes pain and reduced mobility in ... Reversed Shoulder System, which was developed by FX Solutions, ... Lyon, France , received FDA clearance for ...
(Date:2/22/2017)... , Feb 22, 2017 Research and ... Drug Development Pipeline Review, 2016" report to their offering. ... ... disorders worldwide, and approximately one-third of the US population suffers ... decades, the majority of the dermatology market has remained saturated ...
(Date:2/22/2017)... Research and Markets has announced the addition of ... Small Molecule Drugs), By Route of Administration (Systemic, Topical), By ... report to their offering. ... The global psoriasis drugs market is anticipated ... report provides a detailed analysis of the current and future ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... their newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. ... provides instant absorption from the mouth into the bloodstream. Far outpacing ...
(Date:2/22/2017)... ... February 22, 2017 , ... ANGLESTRONG , the new ... now available on the App Store and Google Play . Florida-based ... the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The new recovery ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, a ... innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems are used ... to accelerate tissue synthesis and provide a faster and more efficient healing process. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five ... of those report that family members or friends have also commented about their ... hearing loss wear hearing aids. One reason, suggested by 89 percent of American ...
(Date:2/22/2017)... North Carolina (PRWEB) , ... February 22, 2017 , ... ... of cats and 54% of dogs, according to the Association for Pet Obesity Prevention ... disagreed on key pet food issues such as the benefits of corn and grains, ...
Breaking Medicine News(10 mins):